Western medicine has the advantage of quick effect, but it often leads to adverse consequences due to over treatment, and the side effects can cause single system or multi-system failure in serious cases. The advantage of TCM is that it is effective in relieving symptoms and has a good adjuvant effect on secondary medical damage in cancer radiotherapy, and can target the pathogenic treatment. Professor Yang Chang, a pharmacologist and member of the Yunnan Provincial Science Association, invented the Aromatic Ginseng Soft Capsules, which are made of natural botanicals such as Aromatic Geranium and Bitter Ginseng, and can inhibit the division and growth of cancer cells and make them apoptotic; the Herb and Cancer Transformation Soup created by Zhang Zhengtian, a Chinese medicine practitioner, is based on Musk, Wild Cordyceps, White Flowering Snake Tongue, Whole Worm and Wild Mountain Ginseng, and can rapidly block the pathological process of cancer. Theoretically, early diagnosis and early treatment, early to mid-term surgery and radiotherapy have a few chances of cure (but since patients have already developed into mid-to-late stage when they visit the doctor due to self-conscious symptoms, early treatment is only a good wish), combined with traditional Chinese medicine can play the role of reducing toxicity and increasing effectiveness. After surgery and radiotherapy, the use of Chinese medicine can play a certain role in preventing recurrence and metastasis. The use of traditional Chinese medicine for late stage patients to support the root, reduce pain and improve the quality of life is an effective way of palliative hospice care. Nowadays, the combination of Chinese and Western medicine can complement each other in order to improve the comprehensive curative effect. Surgical treatment usually includes radical surgery, palliative surgery and exploratory surgery. (1) Radical surgery As malignant tumor grows fast and has no envelope on the surface, there is no obvious boundary between it and the surrounding normal tissues, and the local infiltration is powerful and can be metastasized through lymphatic vessels. Therefore, the surgery should completely remove the tumor and its surrounding normal tissues in a certain range and the lymph nodes that may be invaded. This kind of surgery is suitable for patients with limited tumor scope, no distant metastasis and good physical condition. (2) Palliative surgery For advanced patients with extensive tumor, metastasis and cannot perform radical surgery, only part of the tumor can be removed or some symptom-relieving surgery, such as fistula, can be performed to relieve pain, maintain nutrition and prolong life. (3) Exploratory surgery For deep visceral masses, if the nature of the mass cannot be determined through various examinations, it is necessary to open the chest, abdomen or skull to examine the shape of the mass and distinguish its nature with flesh or to take a small piece of biopsy for rapid frozen section examination, so as to make a clear diagnosis before deciding on the surgery and treatment plan, which is exploratory surgery. Radiation therapy Radiation therapy is short for radiotherapy, which is a treatment method that uses high-energy electromagnetic radiation to act on living organisms to change the structure of biological molecules and achieve the purpose of destroying cancer cells. Radiation can treat cancer because cancer cells are sensitive to radiation. Currently, there are two types of radiation used in clinical practice: x-ray therapy and r-ray therapy. Whether radiation therapy is effective for cancer depends on many factors, such as the early or late clinical time, the type of tumor pathology and its sensitivity to radiation, the overall condition of the patient and the surrounding condition of the tumor are all related. The level of tumor sensitivity to radiation is directly proportional to the rate of tumor cell division and rapid growth. The degree of pathological differentiation of the same tumor is inversely proportional to the radiosensitivity, i.e., low differentiation of tumor cells results in high radiosensitivity, while high differentiation results in low radiosensitivity. Therefore, according to the response of tumors to different doses of radiation, they can be divided into three categories: one category is radiation-sensitive tumors, which often disappear when irradiated with 50-60 Gorey, such as lymphoma, seminomatous cell tumor, asexual cell tumor, low-differentiated squamous epithelial cell carcinoma, small cell undifferentiated lung cancer, etc. The other category is moderately sensitive tumors. The other category is moderately sensitive tumors, and the tumor disappears only when irradiated to about 60-70 Gorey. Another category is the tumors that are not sensitive to radiation, whose irradiation is close to or even exceeds the tolerance of normal tissues, and the effect of radiation therapy is very poor, such as certain soft tissue sarcomas and tumors of bone. The radiosensitivity of tumors is also related to their growth patterns. Generally, tumors that grow outwardly, such as papillary, polyp and cauliflower types, are more sensitive, while tumors that grow infiltratively, such as infiltrative and ulcerative types, are less sensitive. Radiation sensitivity is not proportional to radiation cure rate. Tumors with radiosensitivity, although with high local efficacy and fast tumor disappearance, are difficult to cure because of its high malignancy and many chances of distant metastasis. The radioactivity of squamous epithelial carcinoma is medium, but it has less distant metastasis, so the radiation cure rate is higher, such as skin cancer, nasopharyngeal cancer and cervical cancer. In addition, it is more sensitive to lymphosarcoma and medulloblastoma. Highly sensitive ones are multiple myeloma, seminoma, ovarian asexual cell tumor, Ewing’s tumor, nephroblastoma, etc. Highly sensitive tumors can be treated mainly with radiotherapy. The five-year survival rate of radiotherapy for early-stage cervical cancer, nasopharyngeal cancer, tongue cancer, and early-stage esophageal cancer can reach over 90%. Radiotherapy for these cancers in late stage can sometimes achieve certain efficacy. Chemotherapy Chemotherapy is to bring drugs to the whole body through blood vessels and affects all cells in the body. This therapy is sometimes called “cytotoxic therapy” because the drugs used are harmful or even toxic, and all cells in the body, whether malignant or not, are destroyed. There are four clinical applications of chemotherapy: 1. Systemic chemotherapy for advanced or disseminated tumors Because of the lack of other effective treatments for patients with these tumors, chemotherapy is often used at the outset, with the immediate goal of achieving remission. This chemotherapy is usually referred to as induction chemotherapy. If the initial chemotherapy regimen fails, it is called relief therapy when other regimens are used instead. 2. Adjuvant chemotherapy is chemotherapy administered after local treatment (surgery or radiotherapy) for possible micro-metastatic lesions to prevent their recurrence and metastasis. For example, postoperative adjuvant chemotherapy for patients with osteosarcoma, testicular tumor and high-risk breast cancer can significantly improve the efficacy and survival rate or disease-free survival rate. 3. Neoadjuvant chemotherapy For relatively more limited clinical tumors, but with some difficulty in surgical resection or radiation therapy, chemotherapy can be used before surgery or radiation therapy. The purpose is to hope that the tumor shrinks after chemotherapy, so as to reduce the scope of resection and the disability caused by surgery; secondly, chemotherapy can inhibit or eliminate the possible micro metastases and improve the survival rate of patients. It has been proved that neoadjuvant chemotherapy can reduce the scope of surgery for bladder cancer, breast cancer, laryngeal cancer, osteosarcoma and soft tissue sarcoma, non-small cell lung cancer, esophageal cancer and head and neck cancer, or turn inoperable tumors into resectable tumors after chemotherapy. 4.Special route chemotherapy (1) Intracavitary therapy. It includes cancerous intra-thoracic, intra-abdominal and intra-pericardial effusion. Usually, chemotherapeutic drugs (such as mitomycin, cisplatin, 5-fluorouracil, bleomycin) are dissolved or diluted with appropriate amount of fluid and injected into the body cavity of various lesions through the draining catheter, so as to control the malignant body cavity effusion. (2) Intralesional chemotherapy. Leukemia and many solid tumors can invade the central nervous system, and the meninges in particular are the most susceptible. Treatment is usually administered intrathecally by thoracic spinal puncture to allow for a higher concentration of drugs within the hydrocephalus for therapeutic purposes. The drugs commonly used intrathecally are methotrexate and cytarabine. (3) Arterial cannulation chemotherapy. For example, external carotid artery branch cannulation is used to treat head and neck cancer, and hepatic artery cannulation is used to treat primary hepatocellular carcinoma or liver metastasis.